Medical Forum’s Clinical Director Dr Joe Kosterich speaks with renowned nuclear medicine physician Dr Joe Cardaci about the hope generated by targeted radionuclide therapies for people with advanced progressive metastatic disease.

“Finally, after 30 years, we're actively treating patients with malignancies on a much larger scale,” Dr Cardaci says.

Currently these therapies are focusing on metastatic prostate cancer and neuroendocrine tumours, though patients with other tumours and malignancies may be suitable for Theranostics-related clinical trials.

------------

This podcast is exclusively for Australian medical practitioners. The content discussed is not appropriate for non-medical professionals. Please listen to our disclaimer provided at the end of the episode.

The information in this podcast is intended to be general information only and is no way intended to be medical advice, treatment or diagnoses. You acknowledge and agree that nothing in this product may be taken to be medical advice, treatment or a diagnosis by us or our podcast guests, nor are we or they intended to be a substitute for consulting a medical practitioner for your particular circumstances and needs. We do not accept any liability for injury, loss or damage incurred by the use of or reliance on the information provided in this podcast. This podcast may include the views or recommendations of third parties and does not necessarily reflect the views of Medical Forum - we assume no legal liability or responsibility for the accuracy, currency, or completeness of the information. If you require immediate medical attention, please contact 000 immediately or seek alternative and appropriate medical services.

Season 2

Management of Childhood Leukemia with Prof Cathy Cole

Lung Cancer Screening with Prof Fraser Brims

Clinical trials with GenesisCare

Precision medicine for cancer patients with Dr Aviral Singh

Theranostics with Dr Joe Cardaci